Akash Palkhiwala
Analyst · Canaccord Genuity. Please proceed with your question
Thank you, Steve, and good afternoon, everyone. We’re extremely pleased to report strong third fiscal quarter results, demonstrating the resilience of our business in a challenging economic environment. We delivered total revenues of $4.9 billion and non-GAAP earnings per share of $0.86, which was above the high end of our guidance range, primarily driven by stronger results in QTL. In the third quarter, we saw an approximately 20% year-over-year reduction in 3G, 4G, 5G handset shipments due to the impact of COVID-19 relative to our prior planning assumption of a 30% reduction. In addition, we saw a stronger mix with higher shipments in China and developed regions offset by weakness in emerging regions. In QTL, we delivered revenues of $1 billion, and EBT margin of 62%, both above the high end of our guidance range due to higher units and stronger regional mix. Please note our third quarter QTL results do not include any revenues from Huawei settlement or global patent license agreement. In QCT, we delivered MSM shipments of 130 million units, revenues of $3.8 billion and EBT margin of 16%, which was at the high end of our guidance range. The impact of COVID-19 on emerging regions resulted in fewer, low tier MSM units, offset by improved gross margin as a result of favorable mix. QCT revenues and EBT increased 7% and 20% respectively on a year-over-year basis. This performance reflects 5G design traction, RF front-end growth and strength in certain adjacent platforms that benefited from the work-from-home environment. Our non-GAAP combined R&D and SG&A expenses of $1.68 billion were slightly below our guidance. During the third quarter, we paid $733 million in dividends, refinanced $2 billion in debt, and temporarily suspended stock buybacks. I will now provide a financial overview of the resolution with Huawei. We expect to record approximately $1.8 billion of revenue in our fourth fiscal quarter for amounts due under the settlement agreement relating to the prior license period and the new license agreement for the first half of calendar 2020. This amount will be excluded from our non-GAAP results. Please note that this amount is consistent with the framework of our licensing program and incremental to the partial payments received from Huawei under the interim agreement in prior years. In addition, our fourth quarter non-GAAP financial guidance includes estimated QTL revenue from Huawei sales in the September quarter. With the completion of this agreement, we have now licensed all significant handset OEMs worldwide. Turning to the global 3G, 4G, 5G device forecast. Given the ongoing uncertainty around the timing of economic recovery, our fourth fiscal quarter forecast is based on a planning assumption of approximately 15% year-over-year reduction in handset shipments. This planning assumption reflects a gradual recovery in September quarter based on the regional trends we saw in the June quarter. Consistent with our prior expectations, our forecast for the first three quarters of 2020 implies a year-over-year reduction of approximately 10% to the calendar year, total device forecast. However, total units in the fourth quarter will depend on the speed of the economic recovery. Lastly, we are maintaining our forecast of 175 million to 225 million units for calendar 2020 5G devices. In the June quarter, we estimate that the sell-in of 5G devices increased to greater than 50 million units. This data point is a strong leading indicator of our confidence in the 5G handset forecast for the year and our bias towards the high end of this range. Turning to our fourth fiscal quarter financial guidance. We estimate fourth quarter GAAP revenues to be in the range of $7.3 billion to $8.1 billion and GAAP EPS of $2.12 to $2.32, which includes the revenue related to the settlement with Huawei. We expect fourth quarter non-GAAP revenues of $5.5 billion to $6.3 billion and EPS of $1.05 to $1.25. This guidance includes an impact of greater than $0.25 due to the reduction in handset shipments due to COVID-19, including a partial impact from the delay of our 5G flagship phone launch. In QTL, we estimate fourth quarter revenues of $1.2 billion to $1.4 billion and EBT margins of 67% to 71%. At the midpoint, this guidance implies year-over-year revenue growth of 12% driven by the addition of royalty revenues from Huawei, partially offset by our planning assumption of a 15% reduction in handset shipments. In QCT, we expect MSM shipments of 145 million to 165 million units, revenues of $4.3 billion to $4.9 billion, and EBT margins of 17% to 19%. These guidance midpoints imply year-over-year growth of 27% in revenue and 66% in EBT, reflecting the strong execution of our strategy in a challenging economic environment. As we have previously outlined, RF front-end is one of the key drivers of our revenue growth. Our fourth quarter forecast includes revenues of approximately $750 million for 4G, 5G sub-6 and 5G millimeter wave content. We anticipate fourth quarter non-GAAP combined R&D and SG&A expenses to be up approximately 5% sequentially, reflecting normal seasonality in 5G investments. In closing, I want to thank our employees, customers and suppliers for their commitment and partnership during these extraordinary circumstances. Looking forward, we are excited to have a strong foundation of growth across our product and licensing businesses. Thank you. And I’ll now turn the call back to Mauricio.